AAAAAA

   
Results: 1-18 |
Results: 18
Cryptophycins: A novel class of potent antimitotic antitumor depsipeptides
Authors: Shih, C Teicher, BA
Citation: C. Shih et Ba. Teicher, Cryptophycins: A novel class of potent antimitotic antitumor depsipeptides, CUR PHARM D, 7(13), 2001, pp. 1259-1276
Antiangiogenic and anitumor effects of a protein kinase C beta inhibitor in human T98G glioblastoma multiforme xenografts
Authors: Teicher, BA Menon, K Alvarez, E Galbreath, E Shih, C Faul, M
Citation: Ba. Teicher et al., Antiangiogenic and anitumor effects of a protein kinase C beta inhibitor in human T98G glioblastoma multiforme xenografts, CLIN CANC R, 7(3), 2001, pp. 634-640
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
Authors: Herbst, RS Lynch, C Vasconcelles, M Teicher, BA Strauss, G Elias, A Anderson, I Zacarola, P Dang, NH Leong, T Salgia, R Skarin, AT
Citation: Rs. Herbst et al., Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial, CANC CHEMOT, 48(2), 2001, pp. 151-159
Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460NSCLC cells
Authors: Lu, K Dempsey, J Schultz, RM Shih, C Teicher, BA
Citation: K. Lu et al., Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460NSCLC cells, CANC CHEMOT, 47(2), 2001, pp. 170-178
Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation
Authors: Asea, A Mallick, R Lechpammer, S Ara, G Teicher, BA Fiorentino, S Stevenson, MA Calderwood, SK
Citation: A. Asea et al., Cyclooxygenase inhibitors are potent sensitizers of prostate tumours to hyperthermia and radiation, INT J HYPER, 17(5), 2001, pp. 401-414
Effects of the flavonoid drug Quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo
Authors: Asea, A Ara, G Teicher, BA Stevenson, MA Calderwood, SK
Citation: A. Asea et al., Effects of the flavonoid drug Quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo, INT J HYPER, 17(4), 2001, pp. 347-356
Molecular targets and cancer therapeutics: discovery, development and clinical validation
Authors: Teicher, BA
Citation: Ba. Teicher, Molecular targets and cancer therapeutics: discovery, development and clinical validation, DRUG RESIST, 3(2), 2000, pp. 67-73
Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts
Authors: Teicher, BA Chen, V Shih, C Menon, K Forler, PA Phares, VG Amsrud, T
Citation: Ba. Teicher et al., Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts, CLIN CANC R, 6(3), 2000, pp. 1016-1023
Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo
Authors: Liu, PC Menon, K Alvarez, E Lu, K Teicher, BA
Citation: Pc. Liu et al., Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo, INT J ONCOL, 16(3), 2000, pp. 599-610
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents
Authors: Lu, K Shih, C Teicher, BA
Citation: K. Lu et al., Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agents, CANC CHEMOT, 46(4), 2000, pp. 293-304
Antitumor activity of cryptophycins: effect of infusion time and combination studies
Authors: Menon, K Alvarez, E Forler, P Phares, V Amsrud, T Shih, C Al-Awar, R Teicher, BA
Citation: K. Menon et al., Antitumor activity of cryptophycins: effect of infusion time and combination studies, CANC CHEMOT, 46(2), 2000, pp. 142-149
Laboratory models to evaluate new agents for the systemic treatment of lung cancer
Authors: Teicher, BA Frei, E
Citation: Ba. Teicher et E. Frei, Laboratory models to evaluate new agents for the systemic treatment of lung cancer, LUNG BIOL H, 140, 2000, pp. 301-336
The proteasome inhibitor PS-341 in cancer therapy
Authors: Teicher, BA Ara, G Herbst, R Palombella, VJ Adams, J
Citation: Ba. Teicher et al., The proteasome inhibitor PS-341 in cancer therapy, CLIN CANC R, 5(9), 1999, pp. 2638-2645
MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma
Authors: Teicher, BA Alvarez, E Liu, PC Lu, K Menon, K Dempsey, J Schultz, RM
Citation: Ba. Teicher et al., MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma, SEMIN ONCOL, 26(2), 1999, pp. 55-62
Diminished aqueous microviscosity of tumors in murine models measured within vivo radiofrequency electron paramagnetic resonance
Authors: Halpern, HJ Chandramouli, GVR Barth, ED Yu, C Peric, M Grdina, DJ Teicher, BA
Citation: Hj. Halpern et al., Diminished aqueous microviscosity of tumors in murine models measured within vivo radiofrequency electron paramagnetic resonance, CANCER RES, 59(22), 1999, pp. 5836-5841
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin
Authors: Cenni, B Kim, HK Bubley, GJ Aebi, S Fink, D Teicher, BA Howell, S Christen, RD
Citation: B. Cenni et al., Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin, BR J CANC, 80(5-6), 1999, pp. 699-704
Sarcomas
Authors: Teicher, BA
Citation: Ba. Teicher, Sarcomas, HUM CEL CUL, 1, 1999, pp. 1-19
Potentiation of cytotoxic cancer therapies by antiangiogenic agents
Authors: Teicher, BA
Citation: Ba. Teicher, Potentiation of cytotoxic cancer therapies by antiangiogenic agents, CANC DRUG, 3, 1999, pp. 277-316
Risultati: 1-18 |